The page is the record's research on the issuer — no analyst, no rating, no view. # Gelteq Ltd (NASDAQ: GELS) — research page As of 2026-11-08 · us-cm-kg · record version 1 ## Identity and listing The issuer is Gelteq Ltd, listed on NASDAQ under ticker GELS, with ISIN USQ3978B1090. The LEI is not on the record; no GLEIF record with the exact legal name in jurisdiction US-C3 was found. The security type is Non-operating entity type (other). The segment is not on the record. The sector is 2834 Pharmaceutical Preparations and the jurisdiction is Australia. The issuer is listed and not halted. ## The disclosure read The record holds 12 filings in the twelve months to 2026-11-08, across 9 filing days. By type, 7 are results, 4 are directors' dealings and 1 is a regulatory filing. The median gap between filing days is 25.0 days. The latest filing is dated 2026-11-02, is of type regulatory filing, and falls 6 days before the record date. For NASDAQ the median filing count is 52, the median cadence gap is 6.0 days and the median latency is 5.0 days across 4359 issuers. For sector 2834 Pharmaceutical Preparations the median filing count is 63.0, the median cadence gap is 6.0 days and the median latency is 4.0 days across 526 issuers. The issuer's filing count is below the NASDAQ median and below the sector median. Its cadence gap is above both medians. Its latency is above the NASDAQ median and above the sector median. ## Auditor The auditor of record is not on the record, because the latest annual report cover carries no dei:AuditorName tag. The auditor's location is not on the record. The record holds no auditor changes. ## Events and halts The record holds no listing, delisting, name change or segment move lines. The domicile change is not on the record, because EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, because the exchanges' tier transfers are not EDGAR filings. The halt flag reads listed, not halted. ## Orderability The outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04. ## Coverage No research houses were found on the issuer's investor-relations pages read. The count is 0. ## Open research No openly published research notes were found. The count is 0. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth The issuer's years sealed are 2022, 2023, 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12. ## Sources 7 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange) - https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin) - https://data.sec.gov/submissions/CIK0001920092.json (identity.jurisdiction) - https://mcp.us-cm-kg.ai/events/NASDAQ/GELS (the disclosure lines) - https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag) - https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter) - https://mcp.us-cm-kg.ai/record/NASDAQ/GELS (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/us/NASDAQ/GELS · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp